Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Bioluminescent Assays for Sensitive Detection of NAD(P)/NAD(P)H

Part # PS190


Donna Leippe, Mary Sobol, Jolanta Vidugiriene, *Wenhui Zhou, Gediminas Vidugiris, *Troy Good, *Laurent Bernad, *Poncho Meisenheimer, James Cali
Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711;
*Promega BioSciences, LLC, 227 Granada Dr, San Luis Obispo, CA 93401

We have developed a bioluminescent method for monitoring changes in NAD, NADP, NADH and NADPH levels using a homogeneous, one-step, add-and-read protocol for biochemical or cell-based detection. The assays are sensitive, capable of detecting ≤50 nM of these dinucleotides, and have large maximum signal windows (S/B) of ≥100, providing advantages over currently available colorimetric and fluorescent detection methods. The high sensitivity, one-step reagent addition, and no requirement for sample processing, permit an in-well protocol for the assay of cells directly in culture plate wells. Changes in cellular nicotinamide dinucleotide levels can be rapidly monitored in a high-throughput format, facilitating the study of metabolic pathways and the development of therapeutics that target cancer cell metabolism.

Printed in USA.